Article
Blood-based cardiometabolic phenotypes in atrial fibrillation and their associated risk: EAST-AFNET 4 biomolecule study.
Cardiovascular research - 2 Jul 2024
Fabritz Larissa, Chua Winnie, Cardoso Victor R, Al-Taie Christoph, Borof Katrin, Suling Anna, Krause Linda, Kany Shinwan, Magnussen Christina, Wegscheider Karl, Breithardt Guenter, Crijns Harry J G M, Camm A John, Gkoutos George, Ellinor Patrick T, Goette Andreas, Schotten Ulrich, Wienhues-Thelen Ursula-Henrike, Zeller Tanja, Schnabel Renate B, Zapf Antonia, Kirchhof Paulus
Abstract excerpt
AIMS: Atrial fibrillation (AF) and concomitant cardiometabolic disease processes interact and combine to lead to adverse events, such as stroke, heart failure, myocardial infarction, and cardiovascular death. Circulating biomolecules provide quantifiable proxies for cardiometabolic disease processes. The aim of this study was to test whether biomolecule combinations can define phenotypes in patients with AF....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
